High Content Screening Market

High Content Screening Market by Product (Cell Imaging & Analysis System, Flow Cytometry, Consumable, Software, Service) Application (Primary & Secondary Screening, Toxicity Studies, Target Identification & Validation), End User - Global Forecast to 2022

Report Code: BT 2227 Apr, 2017, by marketsandmarkets.com

[166 Pages Report] The overall high content screening market is expected to grow from USD 506.7 million in 2016 to USD 909.0 million by 2022, at a CAGR of 10.3% from 2017 to 2022.

The conventional method of toxicity studies involves the screening of large libraries in search of potential drug candidates. This method is expensive, resource- & time-consuming, and has a low success rate. Hence, HCS solutions for testing the potential toxicity of chemicals and complex substances are being adopted by pharmaceutical companies to improve in vitro toxicity testing by reducing the time and cost. The need for cost containment in pharma R&D, advancements in informatics solutions and imaging instruments, and government funding and venture capital investments across developed markets are the major factors driving the growth of the high-content screening (HCS) market.  The increasing number of contract research organizations providing HCS outsourcing services, and application of HCS in personalized medicine, present significant growth opportunities in the market. The base year considered for the study is 2016, and the forecast has been provided for the period between 2017 and 2022.

Market Dynamics

Drivers

  • Need for cost containment in pharma R&D
  • Government funding and venture capital investments across developed markets
  • Advancements in informatics solutions and imaging instruments

Restraint

  • Lower adoption of HCS instruments due to their high prices

Opportunities

  • Increasing number of CROs providing HCS services
  • Application of HCS in personalized medicine

Challenges

  • Dearth of knowledgeable and skilled operators of HCS instruments
  • Inadequate infrastructure and funding for R&D in emerging countries

Advancements in informatics solutions and imaging instruments drives the global high content screening market

Over the last few years, the HCS market has witnessed significant developments in the quality of cell imaging instruments and imaging analysis solutions. For instance, the Cell Insight CX7 high-content analysis platform, launched by Thermo Fisher Scientific, Inc. in January 2016, is an integration of wide-field and confocal imaging that enables seven-color excitation and laser autofocus. Moreover, various cell analyzers and cell sorters have also been introduced in the market. In December 2015, Becton, Dickinson and Company launched the BD FACSCelesta cell analyzer that offers the simultaneous measurement of up to 14 different single-cell characteristics. These technologically advanced products have enabled researchers to carry out cell image analysis with increased efficiency and reduced costs.

High Content Screening Market

The following are the major objectives of the study.

  • To define, describe, and forecast the global high-content screening market on the basis of product, application, end user, and region
  • To provide detailed information regarding the major factors influencing growth of the global high-content screening market (drivers, restraints, opportunities, and industry-specific challenges)
  • To analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the overall market
  • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the high-content screening market with respect to five main regions (along with countries), namely, North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa
  • To profile the key players in the global high-content screening market and comprehensively analyze their core competencies and their market shares
  • To track and analyze competitive developments such as acquisitions, product launches, collaborations & partnerships, and expansions in the global high-content screening market

During this research study, major players operating in the high content screening market in various regions have been identified, and their offerings, regional presence, and distribution channels have been analyzed through in-depth discussions. Top-down and bottom-up approaches have been used to determine the overall market size. Sizes of the other individual markets have been estimated using the percentage splits obtained through secondary sources such as Hoovers, Bloomberg BusinessWeek, and Factiva, along with primary respondents. The entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews with industry experts such as CEOs, VPs, directors, and marketing executives for key insights (both qualitative and quantitative) pertaining to the market. The figure below shows the breakdown of the primaries on the basis of the company type, designation, and region considered during the research study.

High Content Screening Market

To know about the assumptions considered for the study, download the pdf brochure

The HCS market is highly competitive in nature. The prominent players in the global high-content screening market are GE Healthcare (U.S.), Danaher Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), PerkinElmer, Inc. (U.S.), Tecan Group (Switzerland), BioTek Instruments Inc. (U.S.), Becton, Dickinson and Company (U.S.), Bio-Rad Laboratories (U.S.), Yokogawa Electric Corporation (Japan), and Merck Millipore (U.S.).

Major Market Developments

  • In April 2016, Molecular Devices, LLC launched the ImageXpress Micro 4 High-Content Imaging System. Moreover, in April 2014, Beckman Coulter Life Sciences acquired flow cytometer developer Xitogen Technologies (China). This acquisition further strengthened the company’s offering in basic cellular research.
  • In October 2016, GE Healthcare launched its IN Cell Image Analysis Software, which provided a fully integrated automation solution for its equipment in HCS.
  • In June 2015, PerkinElmer collaborated with Albany Molecular Research Inc. (U.S.) and established a drug discovery center to enable translational research platforms. These strategies enabled the company to maintain a strong foothold in the high-content screening market.

Target Audience

  • Pharmaceutical and biotechnology companies
  • Life sciences instrumentation and reagents companies
  • High-content screening database and software providers
  • High-content screening service providers
  • Business research and consulting firms
  • Academic institutes and government organizations
  • Clinical research organizations (CROs)
  • Government bodies

Report Scope

By Product

  • Instruments
  • Cell Imaging and Analysis Systems
  • Flow Cytometers
    • Cell Analyzers
    • Cell Sorters
  • Consumables
  • Reagents & Assay Kits
  • Microplates
  • Other Consumables
  • Software
  • Services
  • Accessories

By Application

  • Self-Target Identification and Validation
  • Primary Screening and Secondary Screening
  • Toxicity Studies
  • Compound Profiling
  • Other Applications

By End User:

  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations (CROs)
  • Academia and Government Institutes

By Geography

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Switzerland
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Rest of APAC
  • Latin America
  • Middle East & Africa

Critical questions which the report answers

  • What are new application types which the high content screening companies are exploring?
  • Which are the key players in the market and how intense is the competition?

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Geographic Analysis

  • Further breakdown of regional level markets
  • Further breakdown of the Rest of Asia-Pacific high-content screening market into South Korea, Australia, New Zealand, and others
  • Further breakdown of the Rest of Europe high-content screening market into Belgium, Italy, Spain and Denmark
  • Further breakdown of the Latin America high-content screening market into Brazil, Mexico, and others

Company Information

  • Detailed analysis and profiling of additional market players (Up to 5)

The global high content screening market is projected to reach USD 909.0 million by 2022 from USD 557.1 million in 2017 at a CAGR of 10.3% from 2017 to 2022. The need for cost containment in pharma R&D, advancements in informatics solutions and imaging instruments, and government funding and venture capital investments across developed markets are the major factors driving the growth of the high-content screening (HCS) market.

High-content screening (HCS) is a method that is used in biological research and drug discovery to identify substances such as small molecules, peptides, or RNAi that alter the phenotype of a cell in a desired manner. High-content screening includes any method used to analyze whole cells or components of cells with a simultaneous readout of several parameters.

Based on product, the global high content screening market is broadly segmented into instruments, consumables, software, services, and accessories. The market for HCS software is expected to grow at the highest CAGR between 2017 and 2022. Among all high content screening products, instrument segment caters to the largest share. The large share of this segment is attributed to advances in instrumentation and automation techniques and high prices of HCS instruments.

The high content screening market in APAC is expected to grow at the highest CAGR during the forecast period. Factors such as increasing drug discovery research, government initiatives, growing focus of multinational companies on emerging markets, and developing R&D infrastructure are driving the growth of the HCS market in this region.

High Content Screening Market

Rising adoption of high content screenings in applications such as primary & secondary screening, target identification & validation and compound profiling are driving the growth of high content screening market

Primary and Secondary Screening

The major users of HCS for primary and secondary screening are pharmaceutical and biotechnology companies and CROs involved in the drug discovery process. In recent years, the market has witnessed significant developments involving major players and prominent research institutes focusing on the use of HCS in screening applications. In secondary screening, HCS is used in qualitative assays to exclude the compounds with unintended modes of action.

Target Identification and Validation

Target identification and validation is the initial step in the drug discovery process. The benefits of high-content screening are especially relevant in drug discovery. Currently, late-stage failure during drug development can result in significant financial losses for companies. To eliminate this possibility, detailed insights are essential into how a drug or compound acts in a functional context on a cellular pathway. This results in more information and confidence in both hit selection as well as safety & efficacy, prior to lead candidate selection. Thus, target identification is a vital step in the drug discovery process.

Compound Profiling

HCS allows for investigation of a compound’s action on a large number of known targets and the compounds with a high success rate are continued to be developed further through clinical studies. For compound profiling applications, many pharmaceutical companies are partnering with contract research organizations to identify potential candidates for drug discovery. For instance, in January 2017, ChemDiv Inc. (U.S.) entered into a hit identification collaboration with Janssen Research & Development, LLC (U.S.) to identify potent hit candidates for a range of targets across multiple therapeutic areas. The growing use of HCS for hit identification and compound profiling is expected to fuel the growth of this application segment.

Critical questions the report answers:

  • Where will all these applications take the industry in the mid to long term?
  • What are the current industry developments for high content screenings?

Lower adoption of HCS instruments due to their high prices is a major factor restraining the growth of the market. HCS instruments are equipped with advanced cell imaging and analysis features and functionalities and thus are priced at a premium. A confocal microscope can cost more than USD 200,000. The InCell 2000 Analyzer system (from GE Healthcare) used in HCS costs around USD 240,000. The price for a flow cytometer instrument varies from USD 35,000 for simple cell analyzers to above USD 300,000 for more complex systems with higher throughput. Academic research laboratories find it difficult to afford such instruments, as they have restricted budgets.

The prominent players in the global high-content screening market are GE Healthcare (U.S.), Danaher Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), PerkinElmer, Inc. (U.S.), Tecan Group (Switzerland), BioTek Instruments Inc. (U.S.), Becton, Dickinson and Company (U.S.), Bio-Rad Laboratories (U.S.), Yokogawa Electric Corporation (Japan), and Merck Millipore (U.S.). Product launches was the key growth strategy adopted by market players between 2014 and 2017. Companies also aim to differentiate themselves in the highly competitive global high-content screening market by expanding their product portfolios in accordance with industry trends and client needs.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Table of Contents

1 Introduction (Page No. - 17)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
    1.4 Years Considered for the Study
    1.5 Limitations
    1.6 Currency
    1.7 Stakeholders

2 Research Methodology (Page No. - 20)
    2.1 Research Approach
    2.2 Market Size Estimation
    2.3 Market Breakdown and Data Triangulation
           2.3.1 Data From Secondary Sources
           2.3.2 Data From Primary Sources
           2.3.3 Key Industry Insights
    2.4 Assumptions for the Study

3 Executive Summary (Page No. - 28)

4 Premium Insights (Page No. - 32)
    4.1 High-Content Screening: Market Snapshot
    4.2 Europe: High-Content Screening Market, By Application (2016)
    4.3 Geographic Snapshot of the High-Content Screening Market
    4.4 High-Content Screening Market: Regional Mix

5 Market Overview (Page No. - 36)
    5.1 Introduction
    5.2 Key Market Dynamics
           5.2.1 Market Drivers
                    5.2.1.1 Need for Cost Containment in Pharmaceutical R&D
                    5.2.1.2 Government Funding and Venture Capital Investments Across Developed Markets
                    5.2.1.3 Advancements in Informatics Solutions and Imaging Instruments
           5.2.2 Market Restraints
                    5.2.2.1 Lower Adoption of HCS Instruments Due to Their High Prices
           5.2.3 Market Opportunities
                    5.2.3.1 Increasing Number of Cros Providing HCS Services
                    5.2.3.2 Application of HCS in Personalized Medicine
           5.2.4 Market Challenges
                    5.2.4.1 Dearth of Knowledgeable and Skilled Operators of HCS Instruments
                    5.2.4.2 Inadequate Infrastructure and Funding for R&D in Emerging Countries

6 Industry Insights (Page No. - 44)
    6.1 Industry Trends
           6.1.1 Rising Adoption of Label-Free Technologies
           6.1.2 Growing Focus on Stem Cell Analysis
    6.2 Technological Roadmap

7 Global High-Content Screening Market, By Product (Page No. - 47)
    7.1 Introduction
    7.2 Instruments
           7.2.1 Cell Imaging and Analysis Systems
           7.2.2 Flow Cytometers
                    7.2.2.1 Cell Analyzers
                    7.2.2.2 Cell Sorters
    7.3 Consumables
           7.3.1 Reagents & Assay Kits
           7.3.2 Microplates
           7.3.3 Other Consumables
    7.4 Software
    7.5 Services
    7.6 Accessories

8 Global High-Content Screening Market, By Application (Page No. - 63)
    8.1 Introduction
    8.2 Primary and Secondary Screening
    8.3 Target Identification and Validation
    8.4 Toxicity Studies
    8.5 Compound Profiling
    8.6 Other Applications

9 Global High-Content Screening Market, By End User (Page No. - 70)
    9.1 Introduction
    9.2 Pharmaceutical and Biotechnology Companies
    9.3 Academic and Government Institutes
    9.4 Contract Research Organizations

10 High-Content Screening Market, By Region (Page No. - 75)
     10.1 Introduction
     10.2 North America
             10.2.1 U.S.
             10.2.2 Canada
     10.3 Europe
             10.3.1 Germany
             10.3.2 U.K.
             10.3.3 France
             10.3.4 Switzerland
             10.3.5 Rest of Europe
     10.4 Asia-Pacific
             10.4.1 Japan
             10.4.2 China
             10.4.3 India
             10.4.4 Rest of Asia-Pacific
     10.5 Latin America
     10.6 Middle East and Africa

11 Competitive Landscape (Page No. - 117)
     11.1 Overview
     11.2 Competitive Analysis
             11.2.1 Market Players Ranking
             11.2.2 Product Matrix
             11.2.3 Vendor Benchmarking
     11.3 Competitive Situations and Trends
             11.3.1 Product Launches
             11.3.2 Collaborations, Partnerships, and Agreements
             11.3.3 Acquisitions
             11.3.4 Expansions

12 Company Profiles (Page No. - 128)
(Overview, Products and Services, Financials, Strategy & Development)*
     12.1 Introduction
     12.2 GE Healthcare
     12.3 Danaher Corporation
     12.4 Perkinelmer, Inc.
     12.5 Thermo Fisher Scientific Inc.
     12.6 Becton, Dickinson and Company
     12.7 Biotek Instruments, Inc.
     12.8 Bio-Rad Laboratories, Inc.
     12.9 Tecan Group Ltd.
     12.10 Yokogawa Electric Corporation
     12.11 Merck Millipore

*Details on Overview, Products and Services, Financials, Strategy & Development Might Not Be Captured in Case of Unlisted Companies.

13 Appendix (Page No. - 154)
     13.1 Insights of Industry Experts
     13.2 Discussion Guide
     13.3 Other Developments
     13.4 Knowledge Store: Marketsandmarkets’ Subscription Portal
     13.5 Introducing RT: Real-Time Market Intelligence
     13.6 Available Customizations
     13.7 Related Reports
     13.8 Author Details


List of Tables (138 Tables)

Table 1 Market Drivers: Impact Analysis
Table 2 Market Restraints: Impact Analysis
Table 3 Market Opportunities: Impact Analysis
Table 4 Market Challenges: Impact Analysis
Table 5 Global HCS Market Size, By Product, 2015-2022 (USD Million)
Table 6 Global HCS Instruments Market Size, By Type, 2015-2022 (USD Million)
Table 7 Global HCS Instruments Market Size, By Country/Region, 2015-2022 (USD Million)
Table 8 Global Cell Imaging and Analysis Systems Market Size, By Country/Region, 2015-2022 (USD Million)
Table 9 Global Flow Cytometers Market Size, By Type, 2015–2022 (USD Million)
Table 10 Global Flow Cytometers Market Size, By Region/Country, 2015–2022 (USD Million)
Table 11 Global Cell Analyzers Market Size, By Region/Country, 2015-2022 (USD Million)
Table 12 Global Cell Sorters Market Size, By Region/Country, 2015-2022 (USD Million)
Table 13 Global HCS Consumables Market Size, By Type, 2015-2022 (USD Million)
Table 14 Global HCS Consumables Market Size, By Region/Country, 2015-2022 (USD Million)
Table 15 Global Reagents and Assay Kits Market Size, By Region/Country, 2015-2022 (USD Million)
Table 16 Global Microplates Market Size, By Region/Country, 2015-2022 (USD Million)
Table 17 Global Other Consumables Market Size, By Region/Country, 2015-2022 (USD Million)
Table 18 Global HCS Software Market Size, By Region/Country, 2015-2022 (USD Million)
Table 19 Global HCS Services Market Size, By Region/Country, 2015-2022 (USD Million)
Table 20 Global HCS Accessories Market Size, By Region/Country, 2015-2022 (USD Million)
Table 21 Global HCS Market Size, By Application, 2015-2022 (USD Million)
Table 22 Global High-Content Screening Market Size for Primary and Secondary Screening, By Country, 2015-2022 (USD Million)
Table 23 Global Market Size for Target Identification and Validation, By Country, 2015-2022 (USD Million)
Table 24 Global Market Size for Toxicity Studies, By Country, 2015-2022 (USD Million)
Table 25 Global Market Size for Compound Profiling, By Country, 2015-2022 (USD Million)
Table 26 Global Market Size for Other Applications, By Country, 2015-2022 (USD Million)
Table 27 Global Market Size, By End User, 2015-2022 (USD Million)
Table 28 Global Market Size for Pharmaceutical and Biotechnology Companies, By Country, 2015-2022 (USD Million)
Table 29 Global Market Size for Academic and Government Institutes, By Country, 2015-2022 (USD Million)
Table 30 Global Market Size for Contract Research Organizations, By Country, 2015-2022 (USD Million)
Table 31 Global Market, By Region, 2015-2022 (USD Million)
Table 32 North America: Market Size, By Country, 2015-2022 (USD Million)
Table 33 North America: Market Size, By Product, 2015-2022 (USD Million)
Table 34 North America: HCS Instruments Market Size, By Type, 2015-2022 (USD Million)
Table 35 North America: Flow Cytometers Market Size, By Type, 2015-2022 (USD Million)
Table 36 North America: HCS Consumables Market Size, By Type, 2015-2022 (USD Million)
Table 37 North America: Market Size, By Application, 2015-2022 (USD Million)
Table 38 North America: Market Size, By End User, 2015-2022 (USD Million)
Table 39 U.S.: HCS Market Size, By Product, 2015-2022 (USD Million)
Table 40 U.S.: HCS Instruments Market Size, By Type, 2015-2022 (USD Million)
Table 41 U.S.: Flow Cytometers Market Size, By Type, 2015-2022 (USD Million)
Table 42 U.S.: HCS Consumables Market Size, By Type, 2015-2022 (USD Million)
Table 43 U.S.: High-Content Screening Market Size, By Application, 2015-2022 (USD Million)
Table 44 U.S.: High-Content Screening Market Size, By End User, 2015-2022 (USD Million)
Table 45 Canada: High-Content Screening Market Size, By Product, 2015-2022 (USD Million)
Table 46 Canada: HCS Instruments Market Size, By Type, 2015-2022 (USD Million)
Table 47 Canada: Flow Cytometers Market Size, By Type, 2015-2022 (USD Million)
Table 48 Canada: HCS Consumables Market Size, By Type, 2015-2022 (USD Million)
Table 49 Canada: Market Size, By Application, 2015-2022 (USD Million)
Table 50 Canada: Market Size, By End User, 2015-2022 (USD Million)
Table 51 Pharmaceutical R&D Expenditure in Europe, By Country, 2014 (USD Million)
Table 52 Europe: Market Size, By Country, 2015-2022 (USD Million)
Table 53 Europe: Market Size, By Product, 2015-2022 (USD Million)
Table 54 Europe: HCS Instruments Market Size, By Type, 2015-2022 (USD Million)
Table 55 Europe: Flow Cytometers Market Size, By Type, 2015-2022 (USD Million)
Table 56 Europe: HCS Consumables Market Size, By Type, 2015-2022 (USD Million)
Table 57 Europe: Market Size, By Application, 2015-2022 (USD Million)
Table 58 Europe: Market Size, By End User, 2015-2022 (USD Million)
Table 59 Germany: Market Size, By Product, 2015-2022 (USD Million)
Table 60 Germany: HCS Instruments Market Size, By Type, 2015-2022 (USD Million)
Table 61 Germany: Flow Cytometers Market Size, By Type, 2015-2022 (USD Million)
Table 62 Germany: HCS Consumables Market Size, By Type, 2015-2022 (USD Million)
Table 63 Germany: Market Size, By Application, 2015-2022 (USD Million)
Table 64 Germany: HCS Market Size, By End User, 2015-2022 (USD Million)
Table 65 U.K.: Market Size, By Product, 2015-2022 (USD Million)
Table 66 U.K.: HCS Instruments Market Size, By Type, 2015-2022 (USD Million)
Table 67 U.K.: Flow Cytometers Market Size, By Type, 2015-2022 (USD Million)
Table 68 U.K.: HCS Consumables Market Size, By Type, 2015-2022 (USD Million)
Table 69 U.K.: Market Size, By Application, 2015-2022 (USD Million)
Table 70 U.K.: Market Size, By End User, 2015-2022 (USD Million)
Table 71 France: Market Size, By Product, 2015-2022 (USD Million)
Table 72 France: HCS Instruments Market Size, By Type, 2015-2022 (USD Million)
Table 73 France: Flow Cytometers Market Size, By Type, 2015-2022 (USD Million)
Table 74 France: HCS Consumables Market Size, By Type, 2015-2022 (USD Million)
Table 75 France: Market Size, By Application, 2015-2022 (USD Million)
Table 76 France: Market Size, By End User, 2015-2022 (USD Million)
Table 77 Switzerland: Market Size, By Product, 2015-2022 (USD Million)
Table 78 Switzerland:HCS Instruments Market Size, By Type, 2015-2022 (USD Million)
Table 79 Switzerland: Flow Cytometers Market Size, By Type, 2015-2022 (USD Million)
Table 80 Switzerland: HCS Consumables Market Size, By Type, 2015-2022 (USD Million)
Table 81 Switzerland: Market Size, By Application, 2015-2022 (USD Million)
Table 82 Switzerland: Market Size, By End User, 2015-2022 (USD Million)
Table 83 Rest of Europe: Market Size, By Product, 2015-2022 (USD Million)
Table 84 Rest of Europe: HCS Instruments Market Size, By Type, 2015-2022 (USD Million)
Table 85 Rest of Europe: Flow Cytometers Market Size, By Type, 2015-2022 (USD Million)
Table 86 Rest of Europe: HCS Consumables Market Size, By Type, 2015-2022 (USD Million)
Table 87 Rest of Europe: Market Size, By Application, 2015-2022 (USD Million)
Table 88 Rest of Europe: Market Size, By End User, 2015-2022 (USD Million)
Table 89 Asia-Pacific: Market Size, By Country, 2015-2022 (USD Million)
Table 90 Asia-Pacific: Market Size, By Product, 2015-2022 (USD Million)
Table 91 Asia-Pacific: HCS Instruments Market Size, By Type, 2015-2022 (USD Million)
Table 92 Asia-Pacific: Flow Cytometers Market Size, By Type, 2015-2022 (USD Million)
Table 93 Asia-Pacific: HCS Consumables Market Size, By Type, 2015-2022 (USD Million)
Table 94 Asia-Pacific: High-Content Screening Market Size, By Application, 2015-2022 (USD Million)
Table 95 Asia-Pacific: High-Content Screening Market Size, By End User, 2015-2022 (USD Million)
Table 96 Japan: High-Content Screening Market Size, By Product, 2015-2022 (USD Million)
Table 97 Japan: HCS Instruments Market Size, By Type, 2015-2022 (USD Million)
Table 98 Japan: Flow Cytometers Market Size, By Type, 2015-2022 (USD Million)
Table 99 Japan: HCS Consumables Market Size, By Type, 2015-2022 (USD Million)
Table 100 Japan: High-Content Screening Market Size, By Application, 2015-2022 (USD Million)
Table 101 Japan: High-Content Screening Market Size, By End User, 2015-2022 (USD Million)
Table 102 China: High-Content Screening Market Size, By Product, 2015-2022 (USD Million)
Table 103 China: HCS Instruments Market Size, By Type, 2015-2022 (USD Million)
Table 104 China: Flow Cytometers Market Size, By Type, 2015-2022 (USD Million)
Table 105 China: HCS Consumables Market Size, By Type, 2015-2022 (USD Million)
Table 106 China: Market Size, By Application, 2015-2022 (USD Million)
Table 107 China: Market Size, By End User, 2015-2022 (USD Million)
Table 108 India: Market Size, By Product, 2015-2022 (USD Million)
Table 109 India: HCS Instruments Market Size, By Type, 2015-2022 (USD Million)
Table 110 India: Flow Cytometers Market Size, By Type, 2015-2022 (USD Million)
Table 111 India: HCS Consumables Market Size, By Type, 2015-2022 (USD Million)
Table 112 India: Market Size, By Application, 2015-2022 (USD Million)
Table 113 India: Market Size, By End User, 2015-2022 (USD Million)
Table 114 Rest of Asia-Pacific: Market Size, By Product, 2015-2022 (USD Million)
Table 115 Rest of Asia-Pacific: HCS Instruments Market Size, By Type, 2015-2022 (USD Million)
Table 116 Rest of Asia-Pacific: Flow Cytometers Market Size, By Type, 2015-2022 (USD Million)
Table 117 Rest of Asia-Pacific: HCS Consumables Market Size, By Type, 2015-2022 (USD Million)
Table 118 Rest of Asia-Pacific: Market Size, By Application, 2015-2022 (USD Million)
Table 119 Rest of Asia-Pacific: Market Size, By End User, 2015-2022 (USD Million)
Table 120 Latin America: Market Size, By Product, 2015-2022 (USD Million)
Table 121 Latin America: HCS Instruments Market Size, By Type, 2015-2022 (USD Million)
Table 122 Latin America: Flow Cytometers Market Size, By Type, 2015-2022 (USD Million)
Table 123 Latin America: HCS Consumables Market Size, By Type, 2015-2022 (USD Million)
Table 124 Latin America: Market Size, By Application, 2015-2022 (USD Million)
Table 125 Latin America: Market Size, By End User, 2015-2022 (USD Million)
Table 126 Middle East and Africa: High-Content Screening Market Size, By Product, 2015-2022 (USD Million)
Table 127 Middle East and Africa: HCS Instruments Market Size, By Type, 2015-2022 (USD Million)
Table 128 Middle East and Africa: Flow Cytometers Market Size, By Type, 2015-2022 (USD Million)
Table 129 Middle East and Africa: High-Content Screening Consumables Market Size, By Type, 2015-2022 (USD Million)
Table 130 Middle East and Africa: High-Content Screening Market Size, By Application, 2015-2022 (USD Million)
Table 131 Middle East and Africa: High-Content Screening Market Size, By End User, 2015-2022 (USD Million)
Table 132 Global High-Content Screening Market Ranking, By Key Player, 2016
Table 133 High-Content Screening Market: Product Matrix
Table 134 Growth Strategy Matrix (2014–2017)
Table 135 Product Launches, 2014–2017
Table 136 Collaborations, Partnerships, and Agreements, 2014–2017
Table 137 Acquisitions, 2014–2017
Table 138 Expansions, 2014–2017


List of Figures (42 Figures)

Figure 1 Global High-Content Screening Market Segmentation
Figure 2 Research Design
Figure 3 Bottom-Up Approach
Figure 4 Top-Down Approach
Figure 5 Data Triangulation Methodology
Figure 6 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 7 Global High-Content Screening Market Size, By Product, 2017 vs 2022 (USD Million)
Figure 8 Global High-Content Screening Market Size, By Application, 2017 vs 2022 (USD Million)
Figure 9 Global High-Content Screening Market Size, By End User, 2017 vs 2022 (USD Million)
Figure 10 Geographic Snapshot of the Global High-Content Screening Market
Figure 11 The High-Content Screening Market is Projected to Witness A Double-Digit Growth Rate in the Forecast Period
Figure 12 Germany Commanded the Largest Share of the European High-Content Screening Market in 2016
Figure 13 The U.S. Accounted for the Largest Share of the High-Content Screening Market in 2016
Figure 14 APAC to Register the Highest CAGR During the Forecast Period
Figure 15 High-Content Screening Market: Drivers, Restraints, Opportunities, and Challenges
Figure 16 Estimated Pre-Approval Cost of Bringing A New Chemical Or Biological Entity to Market (USD Million)
Figure 17 R&D Expenditure as Percentage of GDP, 2014
Figure 18 Focus on Stem Cell Analysis and Label-Free HCS are the Major Trends in the Market
Figure 19 High-Content Screening: Technological Evolution
Figure 20 Instruments Dominate the Global High-Content Screening Market in 2017
Figure 21 Cell Imaging and Analysis Systems to Dominate the High-Content Screening Instruments Market By 2022
Figure 22 Cell Anyalyzers Segment to Register Highest Growth During the Forecast Period
Figure 23 Primary & Secondary Screening Segment to Register the Highest Growth in the HCS Market During the Forecast Period
Figure 24 Global High-Content Screening Market Size, By End User, 2017 vs 2022 (USD Million)
Figure 25 Geographic Snapshot: High-Content Screening Market
Figure 26 North America Will Continue to Dominate the High-Content Screening Market By 2022
Figure 27 North America: High-Content Screening Market Snapshot
Figure 28 Europe: High-Content Screening Market Snapshot
Figure 29 Asia-Pacific: High-Content Screening Market Snapshot
Figure 30 Product Launches Was the Most-Preferred Strategy Between 2014 and 2017
Figure 31 High-Content Screening: Vendor Benchmarking
Figure 32 Battle for Market Share: Product Launches - the Most Widely Adopted Strategy Between 2014 and 2017
Figure 33 Geographical Revenue Mix of the Top 5 Players in the High-Content Screening Market
Figure 34 GE Healthcare: Company Snapshot (2016)
Figure 35 Danaher Corporation: Company Snapshot (2016)
Figure 36 Perkinelmer, Inc.: Company Snapshot (2016)
Figure 37 Thermo Fisher Scientific Inc.: Company Snapshot (2016)
Figure 38 Becton, Dickinson and Company: Company Snapshot (2016)
Figure 39 Bio-Rad Laboratories, Inc.: Company Snapshot (2016)
Figure 40 Tecan Group Ltd.: Company Snapshot (2016)
Figure 41 Yokogawa Electric Corporation: Company Snapshot (2015)
Figure 42 Merck Millipore: Company Snapshot (2016)


Request for detailed methodology, assumptions & how numbers were triangulated.

Our USP is "Customised multi client reports"-so feel free to provide us specific interest in much greater detail..!!
  • Select all
  • News-Letters with latest Market insights
  • Information & discussion on the relevant new products and services
  • Information & discussion on Market insights and Market information
  • Information & discussion on our events and conferences
    • Select all
    • Email Phone Professional and social network (Linkedin, etc)
Report Code
BT 2227
Published ON
Apr, 2017
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the High Content Screening Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved